Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSPX | ISIN: CA7233308583 | Ticker-Symbol: PI1
Stuttgart
04.11.24
18:58 Uhr
5,750 Euro
+0,050
+0,88 %
1-Jahres-Chart
PINETREE CAPITAL LTD Chart 1 Jahr
5-Tage-Chart
PINETREE CAPITAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
5,7506,25021:52
ACCESSWIRE
225 Leser
Artikel bewerten:
(1)

Pinetree Capital Ltd.: Pinetree Capital Ltd Announces Unaudited Financial Results for the Period Ended June 30, 2024

TORONTO, ON / ACCESSWIRE / July 25, 2024 / Pinetree Capital Ltd. (TSX:PNP) ("Pinetree" or the "Company") today announced its financial results for the three month period ended June 30, 2024. All financial information provided in this press release is unaudited and all figures are in $'000 except per share amounts and shares outstanding.

Unaudited financial results for the period ended June 30, 2024

The following information should be read in conjunction with our annual audited Consolidated Financial Statements, prepared in accordance with International Financial Reporting Standards ("IFRS") and our annual Management Discussion and Analysis for the year ended December 31, 2023, which can be found on SEDAR+ at www.sedarplus.ca.

Selected Financial Information


As at June 30,
2024

As at December 31, 2023

Total assets

$

55,871

$

45,749

Total liabilities

356

377

Book Value

55,515

45,372

Shares outstanding

9,387,000

9,387,000

Book Value per share (BVPS)

$

5.91

$

4.83


Shares Outstanding

Equity
$000's

Book Value per share (BVPS)1
$

Quarterly Expenses
$000's

Expenses as a percentage of BV1

Jun-30-24

9,387,000

55,515

5.91

159

0.3

Mar-31-24

9,387,000

56,485

6.02

179

0.3

Dec-31-23

9,387,000

45,372

4.83

148

0.3

Sep-30-23

9,387,000

41,399

4.41

190

0.5

Jun-30-23

9,387,000

42,111

4.49

260

0.6

Mar-31-23

9,387,000

39,056

4.16

283

0.7

Dec-31-22

9,387,000

39,619

4.22

275

0.7

Sep-30-22

9,387,000

36,550

3.89

293

0.8

1 Refer to "Use of Non-IFRS Financial Measures"

Shares Outstanding and Equity amounts are as at the Quarter End date. Expense amounts are for the Three months ending the Quarter End date

As at June 30, 2024, Pinetree's equity was $55,515 as compared to $45,372 as at December 31, 2023. This resulted in Pinetree's BVPS increasing from $4.83 as at December 31, 2023 to $5.91 as at June 30, 2024. The change represents an increase of $1.08 or 22% in the year to date.

As at June 30, 2024, the Company held equity investments at fair value totaling $50,428, which represented 91% of book value. This compares to equity investments at fair value of $38,428 representing 85% of book value as at December 31, 2023.

Expenses for the twelve months ended June 30, 2024 were $676 which corresponds to 1.2% of book value as at June 30, 2024. This compares to expenses of $1,111 for the twelve months ended June 30, 2023 which corresponds to 2.6% of book value as at June 30, 2023. Included in expenses are foreign exchange fluctuations resulting from cash balances held in currencies other than Canadian Dollars.


Three months ended
June 30,


2024

2023

Net investment gains (losses)

$

(980

)

$

3,160

Other income

173

163

Expenses

159

260

Income tax expense

4

8

Net income (loss) for the period

(970

)

3,055

Earnings (loss) per share - basic & fully diluted

(0.10

)

0.33

The net investment losses for the three months ended June 30, 2024 were $980 (three months ended June 30, 2023 - gains of $3,160) as a result of net realized gains on investments and the net change in unrealized gains (losses).

For the three months ended June 30, 2024, other income totalled $173 as compared to other income of $163 for the three months ended June 30, 2023. Other income is comprised of interest and dividend income of $69 and $104, respectively (three months ended June 30, 2023 - interest and dividend income of $117 and $46, respectively).

Forward Looking Statements

Certain statements herein may be "forward looking" statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Pinetree or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward-looking statements. These forward-looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Pinetree assumes no obligation, except as required by law, to update any forward-looking statements to reflect new events or circumstances.

Non-IFRS Measures, Non-GAAP Measures

BVPS (book value per share) is a non-IFRS (international financial reporting standards) measure calculated as the value of total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. The term BVPS does not have any standardized meaning according to IFRS and therefore may not be comparable to similar measures presented by other companies. There is no comparable IFRS measure presented in Pinetree's consolidated financial statements and thus no applicable quantitative reconciliation for such non-IFRS financial measure. The Company has calculated BVPS consistently for many years and believes that BVPS can provide information useful to its shareholders in understanding its performance and may assist in the evaluation of its business relative to that of its peers.

About Pinetree Capital Ltd.

Pinetree is a value-oriented investment and merchant banking company focused on the technology sector. Pinetree's common shares are listed on the TSX under the symbol "PNP".

For further information:

John Bouffard
Chief Financial Officer
416-941-9600 x 200
jbouffard@pinetreecapital.com
www.pinetreecapital.com

SOURCE: Pinetree Capital Ltd.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.